These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3206724)

  • 1. [Propafenone. An antiarrhythmic agent for both ventricular and supraventricular arrhythmia].
    Madsen JK; Nielsen H; Madsen BK
    Ugeskr Laeger; 1988 Dec; 150(50):3132-3. PubMed ID: 3206724
    [No Abstract]   [Full Text] [Related]  

  • 2. Propafenone: an effective agent for the management of supraventricular arrhythmias.
    Grant AO
    J Cardiovasc Electrophysiol; 1996 Apr; 7(4):353-64. PubMed ID: 8777484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Propafenone on the way into a new world. Profile of the anti-arrhythmia agent].
    Michel D
    Fortschr Med; 1989 Apr; 107(13):81. PubMed ID: 2722109
    [No Abstract]   [Full Text] [Related]  

  • 4. [Propafenone: evaluation of antiarrhythmic efficacy in hyperkinetic ventricular arrhythmia using acute oral test].
    Boriani G; Capucci A; Balducelli M; Frabetti L; Marchesini B; Tomasi L; Ambrosioni E; Magnani B
    Cardiologia; 1988 Nov; 33(11):1061-7. PubMed ID: 2475253
    [No Abstract]   [Full Text] [Related]  

  • 5. [The treatment of arrhythmias in infants and children using propafenone].
    Dressler F; Grävinghoff L; Grütte E; Jüngst BK; Liersch R; Nomayo H; Puls I; Rautenburg HW; Schmaltz A; Schumacher G
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):154-7. PubMed ID: 4010670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic propafenone: improving patient outcomes.
    Brzozowski LA
    Dimens Crit Care Nurs; 1993; 12(3):116-22. PubMed ID: 8508716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Propafenone in the treatment of high-risk ventricular arrhythmias].
    Pepi R; Rotatori D; Mori A; Nascimbeni F
    Clin Ter; 1986 Aug; 118(4):247-52. PubMed ID: 3757464
    [No Abstract]   [Full Text] [Related]  

  • 8. Propafenone for cardiac arrhythmias.
    Med Lett Drugs Ther; 1990 Apr; 32(816):37-8. PubMed ID: 2182990
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of propafenone on arrhythmias induced by exertion in patients with ischemic cardiopathy].
    Patané S; Virga T; Giannetto M; Luzza F; Oreto G; Arrigo F
    G Ital Cardiol; 1987 Jul; 17(7):605-8. PubMed ID: 3678712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propafenone (rythmol) for ventricular arrhythmias.
    Porterfield LM
    Adv Clin Care; 1990; 5(5):41. PubMed ID: 2393507
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of mortality in patients treated with propafenone to those treated with a variety of antiarrhythmic drugs for supraventricular arrhythmias.
    Pritchett EL; Wilkinson WE; Clair WK; McCarthy EA
    Am J Cardiol; 1993 Jul; 72(1):108-10. PubMed ID: 8517417
    [No Abstract]   [Full Text] [Related]  

  • 12. [Propafenone--a promising anti-arrhythmia agent?].
    Rozsíval V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1990; 33(4):359-63. PubMed ID: 2130480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia].
    Manz M; Beermann J; Gerckens U; Lüderitz B
    Z Kardiol; 1986 Dec; 75(12):757-63. PubMed ID: 3825226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The study of acute clinical electrophysiological effects of propafenone on paroxysmal supraventricular tachycardia using transesophageal atrial pacing technique].
    Li Q; Wang Z; Peng D
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(2):123-6. PubMed ID: 9868052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
    Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Propafenone as an anti-arrhythmia agent].
    Tomaszewski A; Kleinrok A; Markiewicz M
    Wiad Lek; 1986 Nov; 39(21):1479-83. PubMed ID: 3577161
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical evidence of the antiarrhythmic effect of a magistral suspension of propafenone: a case report.
    Barranco-Garduño L; Flores-Pérez J; Juárez-Olguín H; Bobadilla-Chávez J; Osnaya H; Flores-Pérez C
    Arch Cardiol Mex; 2009; 79(2):132-4. PubMed ID: 19722384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic efficacy and tolerance of oral propafenone in patients with frequent ventricular arrhythmias: experience of a multicentre study.
    Geibel A; Meinertz T; Zehender M; Vitak J; Hohnloser S; Kunz-Fritze A; Just H
    Eur Heart J; 1989 Sep; 10 Suppl E():81-7. PubMed ID: 2680506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.